Tokyo, Aug. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062436) titled 'Clinical implications of myositis autoantibody levels in people living with myositis' on Aug. 1.
Study Type:
Observational
Primary Sponsor:
Institute - International Myositis Assessment and Clinical Studies Group (IMACS)
Condition:
Condition - Idiopathic inflammatory myopathies
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the association of myositis-specific autoantibody (MSA) levels, as measured by enzyme-linked immunosorbent assay (ELISA), with myositis disease activity measures in patients with idiopathic inflammatoory myopathies (IIMs).
Basic ...